Skip to main content
. 2021 Mar 8;12:625562. doi: 10.3389/fmicb.2021.625562

FIGURE 4.

FIGURE 4

Principal component analysis (PCA) of clinical data. From PCA (R2X, 0.451; Q2, 0.0698), individual data sets were labeled as before and after the overall clinical trial (A) or before and after the clinical trial of each bacterial strain (B).